Key Highlights
- On March 31, 2026, ARK Invest acquired approximately $240 million in OpenAI Group stock distributed across three exchange-traded funds
- The investment coincided with OpenAI’s record-breaking $122 billion funding round that valued the artificial intelligence leader at $852 billion
- ARK simultaneously increased holdings in CoreWeave and DoorDash during the same trading session
- The investment firm divested more than 600,000 Strata Critical Medical shares and reduced exposure to Veracyte and Teradyne
- This strategic move marks the first time retail ETF investors gain indirect exposure to the private AI company through ARK’s publicly available funds
Cathie Wood’s investment management company, ARK Invest, executed one of its most significant single-session transactions on March 31, 2026, acquiring approximately $240 million in OpenAI Group equity distributed across three exchange-traded funds under its management.
The substantial investment was distributed among the ARK Innovation ETF, ARK Next Generation Internet ETF, and ARK Blockchain and Fintech Innovation ETF. Following this transaction, each fund maintains approximately 3% ownership in OpenAI Group PBC, Series C shares.
Prior to this strategic allocation, only ARK’s closed-end Venture Fund maintained positions in OpenAI securities. That particular fund initially established its position in 2024 and subsequently deployed an additional $250 million investment in October of that same year.
The investment timing coincided precisely with a significant capital raise announcement from OpenAI. On March 31, OpenAI successfully completed its most substantial fundraising event to date, securing $122 billion and elevating the company’s valuation to $852 billion.
According to OpenAI’s statement, the capital will be allocated toward semiconductor acquisitions, data center infrastructure expansion, and talent recruitment. Additionally, the artificial intelligence company facilitated approximately $3 billion in direct share sales to individual investors through a private placement arrangement coordinated by three prominent financial institutions.
OpenAI’s Chief Financial Officer, Sarah Friar, emphasized the company’s commitment to democratizing investment opportunities, stating the organization aims to provide retail investors access not only to its technological innovations but also to the corresponding financial returns.
Implications of OpenAI ETF Integration for Individual Investors
By incorporating OpenAI securities into publicly accessible ETFs, ARK Invest has established a pathway for mainstream investors to gain exposure to a privately held enterprise. This represents an unconventional approach, as private company equity typically remains inaccessible to retail market participants until an initial public offering occurs.
However, this structure presents certain complexities. While ETFs maintain continuous trading throughout market hours, private company valuations lack real-time pricing mechanisms. Portfolio managers must rely on periodic valuation assessments for these holdings and may need to liquidate more liquid positions to accommodate shareholder redemption requests.
Cathie Wood addressed the transaction, noting that within the financial technology ecosystem, agentic artificial intelligence is positioned to generate exceptional investment opportunities.
Additional Portfolio Adjustments by ARK on March 31
Beyond the OpenAI allocation, ARK Invest purchased 26,515 shares of CoreWeave, a cloud computing infrastructure provider, representing approximately $2.05 million in capital. CoreWeave’s stock price appreciated 12% during that trading session.
ARK also expanded its position in DoorDash by acquiring 14,729 shares valued at $2.21 million. This transaction followed a previous DoorDash purchase executed one day earlier, demonstrating ARK’s continued confidence in the food delivery platform sector.
Regarding portfolio reductions, ARK liquidated 612,483 shares of Strata Critical Medical, generating $2.56 million in proceeds. Strata Critical Medical specializes in urgent logistics and medical service provision to healthcare institutions throughout the United States.
Additionally, ARK divested 6,204 Teradyne shares for $1.84 million and sold 115,718 Veracyte shares across its ARKK and ARKG ETF portfolios, totaling $3.52 million. The firm had been systematically reducing its Veracyte allocation throughout the preceding week.
The OpenAI financing event concluded with an $852 billion valuation on March 31, 2026, precisely when ARK executed its $240 million acquisition across its three primary exchange-traded funds.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
